Table 2.

The percentage of total users who discontinued their contraceptive method either during clinical trials or everyday use, specifically due to adverse events or worries about possible adverse events. The data on discontinuation from everyday use was measured over a four-year period in the United States.

DISCONTINUATION	Discontinuation due to adverse events (%)
Contraceptive	Men	Women	Sample size	Publication
Injectable Combination Male Contraceptive	6.25		320	Behre et al 2016
Depo-provera Injection		36.6	12529	Daniels et al 2013
Patch		25.8	5631	Daniels et al 2013
COC		22.71	45021	Daniels et al 2013
COC		6.0	1056	Yaz (2017)
COC		6.7	2837	Yasmin (2017)
COC		4.0	1723	Ortho Tri Cyclen-Lo (2019)
Vaginal Ring		13	2501	NuvaRing® (2017)